Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats

Diabetes

Volumn 45, Issue 12, 1996, Pages 1694-1700

  Kochakian, Maral ^a   Manjula, Belur N ^a,b   Egan, John J ^a  

^a Alteon Inc   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 3,5 DIAMINO 4 HYDROXYBENZOIC ACID; 4 AMINO 3 HYDRAZINO 5 ISOPROPYL 4H 1,2,4 TRIAZOLE; ALT 462; ALT 486; AMINOGUANIDINE; BENZOIC ACID DERIVATIVE; COLLAGEN; GLYCOSYLATED PROTEIN; HYDROXYPROLINE; LYSOZYME; PEPSIN A; PROTEIN INHIBITOR; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RAT; SOLUBILITY; STREPTOZOCIN DIABETES; TAIL; TENDON;

EID: 0029967887     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.12.1694     Document Type: Article

References (44)

1. Hamlin CR, Kohn RR, Luschin JH: Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes 24:902-904, 1975
2. Schnider SL, Kohn RR: Glucosylation of human collagen in aging and diabetes mellitus. J Clin Invest 66:1179-1181, 1980
3. Schnider SL, Kohn RR: Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. J Clin Invest 67:1630-1635, 1981
4. Monnier VM, Sell DR, Abdul-Karim FW, Emancipator SN: Collagen browning and cross-linking are increased in chronic experimental hyperglycemia: relevance to diabetes and aging. Diabetes 37:867-872, 1988
5. Kohn RR, Cerami A, Monnier VM: Collagen aging in vitro by nonenzymatic glycosylation and browning. Diabetes 33:57-59, 1984
6. Kent MJC, Light ND, Bailey AJ: Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. Biochem J 225:745-752, 1985
7. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A: Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632, 1986
8. Bucala R, Cerami A: Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23:1-33, 1992
9. Fu M, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW: Glycation, glycoxidation, and cross-linking of collagen by glucose: kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43:676-683, 1994
10. Monnier VM, Kohn RR, Cerami A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81:583-587, 1984
11. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
12. Cho HK, Kozu H, Peyman GA, Parry GJ, Khoobehi B: The effect of aminoguanidine on the blood-retinal barrier in streptozotocin-induced diabetic rats. Ophthalmic Surg 22:44-47, 1991
13. Mitsuhashi T, Nakayama H, Itoh T, Kuwajima S, Aoki S, Atsumi T, Koike T: Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes 42:826-832, 1993
14. Nakayama H, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, Itoh T, Nakagawa S: Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin-induced diabetic rat. Diabetes 42:345-350, 1993
15. Machete Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Hematol 267:5133-5138, 1992
16. Itakura M, Yoshikawa H, Bannai C, Kato M, Kunika K, Kawakami Y, Yamaoka T, Yamashita K: Aminoguanidine decreases urinary albumin and high molecular weight proteins in diabetic rats. Life Sciences 49:889-897, 1991
17. Ellis EN, Good BH: Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40:1016-1019, 1991
18. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA: Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci USA 88:6107-6111, 1991
19. Cameron NE, Cotter MA, Dines K, Love A: Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35:946-950, 1992
20. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88:11555-11558, 1991
21. Schnider SL, Kohn RR: Effects of age and diabetes mellitus on the solubility of collagen from human skin, tracheal cartilage and dura mater. Exp Gerontol 17:185-194, 1982
22. Kohn RR: Effect of age and diabetes mellitus on cyanogen bromide digestion of human dura mater collagen. Connect Tissue Res 11:169-173, 1983
23. Vogt BW, Schleicher ED, Wieland OH: Epsilon-amino-lysine-bound glucose in human tissues obtained at autopsy: increase in diabetes mellitus. Diabetes 31:1123-1127, 1982
24. Brennan M: Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats. J Biol Hematol 264:20947-20952, 1989
25. Emilsson, H: Synthesis and antihypertensive activity of 5-substituted 4- amino-3-hydrazino-4H-1,2,4-triazoles and the corresponding 3-(2,6- dichlorobenzylidene-hydrazino) derivatives. Acta Pharmaceutica Nordica 2:67-74, 1989
26. Simandi L, Zahonyi D, Jaki M, Szeverenyi Z, Hajdu F, Kovacs G: Preparation of ioxynil and bromoxynil. Hungarian Patent HU 53602 A2 901128, 1990
27. Hamlin CR, Kohn RR: Evidence for progressive, age-related structural changes in post-mature human collagen. Biochim Biophys Acta 236:458-467, 1971
28. Stegemann H, Stalder K: Determination of hydroxyproline. Clin Chim Acta 18:267-273, 1967
29. Maekawa T, Rathinasamy TK, Altman KI, Forbes WF: Changes in collagen with age. I. The extraction of acid soluble collagens from the skin of mice. Exp Gerontol 5:177-186, 1970
30. Mallon VM, Ulrich PC, Boyd TA, Miyauchi Y, Takasu T, Yamin MA: N-[2- (4-Morpholino)ethyl]-N'-aminoguanidine inhibits AGE formation in vitro and diabetic changes in STZ-diabetic rats without inhibiting diamine oxidase or nitric oxide synthase. Diabetes 42 (Suppl. 1):106A, 1993
31. Vasan S, Netram K, Zhang X, Wagle D, Ramdass R, Shih D: Identification of new inhibitors of AGE-protein cross-linking using a novel ELISA. Diabetes 45 (Suppl. 2):72A, 1996
32. Hodge JE: Dehydrated foods: chemistry of browning reactions in model systems. Agric Food Hem 1:928-943, 1953
33. Dunn JA, Patrick JS, Thorpe SR, Baynes JW: Oxidation of glycated proteins: age-dependent accumulation of N'-(carboxvmethyl)lysine in lens proteins. Biochemistry 28:9464-9468, 1989
34. Dunn JA, McCance DR, Thorpe SR, Lyons TJ, Baynes JW: Age-dependent accumulation of N'-(carboxymethyl)lysine and N'-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 30:1205-1210, 1991
35. Sell DR, Monnier VM: End-stage renal disease and diabetes catalyze the formation of a pentose-derived cross-link from aging human collagen. J Clin Invest 75:380-384, 1990
36. Wolff SP, Jiang ZY, Hunt JV: Protein glycation and oxidauve stress in diabetes mellitus and aging. Free Radic Biol Med 10:339-352, 1991
37. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW: Formation of pentosidine during nonenzymatic browning of protein by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 266:11654-11660, 1991
38. Hayashi T, Namiki M: Role of sugar fragmentation in the Maillard reaction. In Amino-carbonyl Reactions in Food and Biological Systems. Fujimaki M, Namiki M, Kato H, Eds. Amsterdam, Holland, Elsevier, 1986, p. 29-38
39. Lyons TJ: Glycation, oxidation, and glycoxidation reactions in the development of diabetic complications. Contrib Nephrol 112:1-10, 1995
40. Chen HC, Cerami A: Mechanism of inhibition of glycosylation by amino- guanidine in vitro. J Carbohydr Chem 12:731-742, 1993
41. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
42. Fu MX, Blackledge JA, Dyer DG, Huggins TG, Richardson JM, Thorpe SR, Hirsh J, Feather MS, Baynes JW: Glycation and oxidation of protein in diabetes and aging. Diabetes Res Clin Pract 8 (Suppl. 1):369-372, 1991
43. Hirsh J, Baynes JW, Blackledge JA, Feather MS: The reaction of 3-deoxy D-glycero-pentos-2-ulose ("3-deoxyglucosone") with aminoguanidine. Carbohydr Res 220:5-7, 1991
44. Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation and product inhibition by aminoguanidine. Diabetes 41:26-29, 1992